• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

齐墩果咸味零食的随机、双盲、安慰剂对照、消费者再激发试验。

Randomized, double-blind, placebo-controlled, consumer rechallenge test of Olean salted snacks.

作者信息

Zorich N L, Biedermann D, Riccardi K A, Bishop L J, Filloon T G

机构信息

Department of Medical Affairs, OLEAN, Procter & Gamble Company, Cincinnati, Ohio 45224, USA.

出版信息

Regul Toxicol Pharmacol. 1997 Oct;26(2):200-9. doi: 10.1006/rtph.1997.1164.

DOI:10.1006/rtph.1997.1164
PMID:9356283
Abstract

Olestra is a zero-calorie fat substitute that is neither digested nor absorbed. A randomized, double-blind, placebo-controlled, within-subject, crossover rechallenge study was conducted to compare the occurrence of gastrointestinal symptoms after ingestion of chips made with Olean brand of olestra or conventional triglycerides in subjects who had previously experienced gastrointestinal symptoms they attributed to consuming Olean. A total of 57 male or female subjects received 2 oz of Olean potato chips or triglyceride potato chips at each of four weekly site visits. The occurrence of gastrointestinal effects after product consumption was noted in follow-up telephone interviews 3 to 5 days after each visit. There was no significant difference in the frequency of any gastrointestinal symptoms (abdominal cramping, diarrhea, loose stools) following consumption of Olean chips or triglyceride chips, and the severity of diarrhea, loose stools, and abdominal cramping was similar. We conclude that consumption of a 2-oz serving of Olean chips is no more likely to result in reports of gastrointestinal symptoms than consumption of triglyceride snacks as a part of the usual diet, even in individuals who have claimed intolerance to Olean. The data suggest that subjects who previously experienced symptoms that they attributed to consuming products made with Olean may have mistakenly attributed their symptoms to these products.

摘要

奥利斯特拉是一种零热量的脂肪替代品,既不被消化也不被吸收。进行了一项随机、双盲、安慰剂对照、受试者自身交叉再激发研究,以比较在曾经历过他们认为是食用含奥利斯特拉的奥力安品牌产品所致胃肠道症状的受试者中,摄入用奥力安牌奥利斯特拉或传统甘油三酯制成的薯片后胃肠道症状的发生情况。共有57名男性或女性受试者在每周一次的四个研究点访视中,每次都接受2盎司的奥力安薯片或甘油三酯薯片。在每次访视后3至5天的随访电话访谈中记录食用产品后胃肠道效应的发生情况。食用奥力安薯片或甘油三酯薯片后,任何胃肠道症状(腹部绞痛、腹泻、稀便)的发生频率均无显著差异,腹泻、稀便和腹部绞痛的严重程度也相似。我们得出结论,作为日常饮食的一部分,食用2盎司的奥力安薯片与食用甘油三酯零食相比,引发胃肠道症状报告的可能性并不更高,即使是那些声称对奥力安不耐受的个体。数据表明,那些曾经历过他们认为是食用含奥利斯特拉产品所致症状的受试者,可能错误地将其症状归因于这些产品。

相似文献

1
Randomized, double-blind, placebo-controlled, consumer rechallenge test of Olean salted snacks.齐墩果咸味零食的随机、双盲、安慰剂对照、消费者再激发试验。
Regul Toxicol Pharmacol. 1997 Oct;26(2):200-9. doi: 10.1006/rtph.1997.1164.
2
Randomized, double-blind, placebo-controlled, food allergy challenge to olestra snacks.对奥利斯特拉零食进行随机、双盲、安慰剂对照的食物过敏激发试验。
Regul Toxicol Pharmacol. 2001 Oct;34(2):178-81. doi: 10.1006/rtph.2001.1488.
3
Effects of olestra and sorbitol consumption on objective measures of diarrhea: impact of stool viscosity on common gastrointestinal symptoms.食用奥利司他和山梨醇对腹泻客观指标的影响:粪便粘度对常见胃肠道症状的影响。
Regul Toxicol Pharmacol. 2000 Feb;31(1):59-67. doi: 10.1006/rtph.1999.1368.
4
Gastrointestinal symptoms following consumption of olestra or regular triglyceride potato chips: a controlled comparison.食用奥利司他或常规甘油三酯薯片后的胃肠道症状:一项对照比较。
JAMA. 1998 Jan 14;279(2):150-2. doi: 10.1001/jama.279.2.150.
5
Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms.对膳食脂肪替代品蔗糖聚酯对胃肠功能及症状影响的综述与分析。
Regul Toxicol Pharmacol. 1997 Oct;26(2):210-8. doi: 10.1006/rtph.1997.1165.
6
Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial.3181名食用含奥利司他或甘油三酯休闲食品的志愿者的胃肠道症状。一项为期6周的随机、安慰剂对照试验。
Ann Intern Med. 1999 Feb 16;130(4 Pt 1):253-61. doi: 10.7326/0003-4819-130-4_part_1-199902160-00002.
7
Effects of wheat bran and Olestra on objective measures of stool and subjective reports of GI symptoms.麦麸和蔗糖聚酯对粪便客观指标及胃肠道症状主观报告的影响。
Am J Gastroenterol. 2000 May;95(5):1244-52. doi: 10.1111/j.1572-0241.2000.02017.x.
8
Olestra Postmarketing Surveillance Study: design and baseline results from the sentinel site.奥利斯特拉上市后监测研究:哨点的设计与基线结果
J Am Diet Assoc. 1998 Nov;98(11):1290-6. doi: 10.1016/S0002-8223(98)00289-2.
9
Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy.
Pharmacotherapy. 1999 Sep;19(9):1075-9. doi: 10.1592/phco.19.13.1075.31599.
10
Postmarketing surveillance of new food ingredients: design and implementation of the program for the fat replacer olestra.
Regul Toxicol Pharmacol. 2001 Apr;33(2):218-23. doi: 10.1006/rtph.2001.1461.

引用本文的文献

1
Authors' financial relationships with the food and beverage industry and their published positions on the fat substitute olestra.作者与食品饮料行业的财务关系以及他们对脂肪替代品蔗糖聚酯发表的立场。
Am J Public Health. 2003 Apr;93(4):664-9. doi: 10.2105/ajph.93.4.664.
2
Olestra formulation and the gastrointestinal tract.奥利斯特拉配方与胃肠道。
Lipids. 1999 Aug;34(8):771-83. doi: 10.1007/s11745-999-0423-3.